Survey Study on Financial Toxicity for Head and Neck Cancer
(PaRTNer Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on financial aspects rather than treatment changes, so you likely won't need to stop them.
Is the financial toxicity survey study safe for participants?
How does this treatment for head and neck cancer differ from other treatments?
This study focuses on the financial impact of head and neck cancer treatments, which is a unique aspect compared to other studies that typically focus on medical outcomes. It highlights the financial burden patients face, which can affect their quality of life and survival, making it an important consideration in treatment planning.12678
What is the purpose of this trial?
The purpose of this single institution, pilot study is to explore the out of pocket (OOP)costs and financial toxicity of cancer care for patients during definitive treatment of head and neck cancer with radiation therapy with or without chemotherapy and surgical resection. The study team will assess how the financial burden of cancer care impacts quality of life as well as treatment-related decision-making from a patient perspective.
Research Team
David Brizel Brizel, MD
Principal Investigator
Duke University Health System (DUHS)
Eligibility Criteria
This study is for adult patients with head and neck cancer (HNC) who are set to undergo radiation therapy, with or without chemotherapy, or surgical resection. Participants must be able to read and write in English and provide informed consent. Those with metastatic disease, recurrent disease, or previous radiation treatments not approved by the principal investigator cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline survey assessing socioeconomic household information, baseline symptoms/QOL, and baseline costs/financial toxicity
Treatment
Participants undergo definitive treatment involving radiation therapy, with or without chemotherapy and surgical resection
Follow-up
Participants are re-surveyed at 3 and 6 months after completion of radiation therapy to assess treatment costs, PROs including QOL, financial toxicity, and self-reported quality of care
Long-term Follow-up
Disease status and survival are assessed from standard of care follow-up visits up to five years after completion of radiation treatment
Treatment Details
Interventions
- Demographics questionnaires and the FACT HN questionnaire
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor